Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Rhea-AI Summary

Collegium Pharmaceutical (Nasdaq: COLL) has announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference in New York, NY from September 9-11, 2024. The company's management will engage in a fireside chat on Monday, September 9, 2024, at 12:30 p.m. ET.

As a leading diversified specialty pharmaceutical company, Collegium is dedicated to improving the lives of people with serious medical conditions. The fireside chat will be webcast live and can be accessed through the Investors section of Collegium's website. A replay of the webcast will remain available on the company's website for 90 days following the presentation, providing investors and interested parties with extended access to the discussion.

STOUGHTON, Mass., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that management will participate in a fireside chat at the H.C. Wainwright 26^th Annual Global Investment Conference being held in New York, NY from September 9-11, 2024.

Details of the event are as follows:
Fireside Chat Date and Time: Monday, September 9, 2024, at 12:30 p.m. ET

The fireside chat will be webcast live and can be accessed from the Investors section of the Company's website: https://ir.collegiumpharma.com A replay of the webcast will be archived on the Company's website for 90 days following the presentation.

About Collegium Pharmaceutical, Inc.
Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.

Investor Contact:
Christopher James, M.D.                                                                                       
Vice President, Investor Relations
ir@collegiumpharma.com 

Media Contact:
Marissa Samuels
Vice President, Corporate Communications
communications@collegiumpharma.com 

FAQ

When is Collegium Pharmaceutical (COLL) participating in the H.C. Wainwright Global Investment Conference?

Collegium Pharmaceutical (COLL) is participating in the H.C. Wainwright 26th Annual Global Investment Conference from September 9-11, 2024, with a fireside chat scheduled for Monday, September 9, 2024, at 12:30 p.m. ET.

How can investors access Collegium Pharmaceutical's (COLL) fireside chat at the H.C. Wainwright conference?

Investors can access Collegium Pharmaceutical's (COLL) fireside chat via a live webcast through the Investors section of the company's website at https://ir.collegiumpharma.com.

How long will the replay of Collegium Pharmaceutical's (COLL) fireside chat be available?

The replay of Collegium Pharmaceutical's (COLL) fireside chat will be archived on the company's website for 90 days following the presentation.

What is the focus of Collegium Pharmaceutical (COLL) as a company?

Collegium Pharmaceutical (COLL) is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions.